These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15345077)

  • 1. Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers.
    Duarte-Franco E; Franco EL
    BMC Womens Health; 2004 Aug; 4 Suppl 1(Suppl 1):S14. PubMed ID: 15345077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
    Gwinn ML
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of endometrial, ovarian, vulvar, and vaginal cancers after a positive cervical cytology followed by negative histology.
    Viikki M; Pukkala E; Hakama M
    Obstet Gynecol; 1998 Aug; 92(2):269-73. PubMed ID: 9699765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
    Schlesselman JJ
    Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoplastic effects of oral contraceptives.
    Grimes DA
    Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraception and cancer of the female reproductive system.
    Woods KL
    J Clin Hosp Pharm; 1985 Jun; 10(2):123-35. PubMed ID: 3894428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
    Ngamkham J; Boonmark K; Phansri T
    Asian Pac J Cancer Prev; 2016; 17(3):1129-34. PubMed ID: 27039737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pill and cancer: a review of the literature. A case of swings and roundabouts?
    Knowlden HA
    J Adv Nurs; 1990 Sep; 15(9):1016-20. PubMed ID: 2229699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]   [Full Text] [Related]  

  • 14. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
    Nygård M; Hansen BT; Dillner J; Munk C; Oddsson K; Tryggvadottir L; Hortlund M; Liaw KL; Dasbach EJ; Kjær SK
    PLoS One; 2014; 9(2):e88323. PubMed ID: 24505474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use?
    Khoo SK
    Med J Aust; 1986 Feb; 144(4):185-90. PubMed ID: 3511357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal microbiota and gynecological cancers: a complex and evolving relationship.
    Javadi K; Ferdosi-Shahandashti E; Rajabnia M; Khaledi M
    Infect Agent Cancer; 2024 Jun; 19(1):27. PubMed ID: 38877504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No. 385-Indications for Pelvic Examination.
    Evans D; Goldstein S; Loewy A; Altman AD
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
    Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
    Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.